Regulatory Affairs Professionals Society· @RAPSorg · X·· 2026-08-15精选AI 评分42
AI 导读
行业及其他利益相关方希望FDA在修订药品和医疗器械企业如何与支付方等利益相关方沟通的指南时，提供更多明确性并确保灵活性。相关诉求通过RAPS发布的链接可进一步查看。
推荐理由
行业对FDA修订版沟通指南提出明确性与灵活性诉求，可了解药械企业与支付方沟通的监管边界争议。
正文
Industry and other stakeholders want FDA to provide more clarity and ensure flexibility in a revised guidance on how drug and medical device makers should communicate with payors and other stakeholders about their products.
https://hubs.la/Q04t1X530
来源：Regulatory Affairs Professionals Society · x.com